Advances in drug development for the treatment of bipolar disorder remain incremental and have come largely from repurposing drugs used for other psychiatric conditions, a strategy that has failed to find truly revolutionary therapies, as it does not target the mood instability that characterises the condition
December 2018.
Bezinover D, Douthitt L, McQuillan PM, Khan A, Dalal P, Stene J, Uemura T, Kadry Z, Janicki PK
The unknown factors that come with compounding only leave more room for added risks in the safety and efficacy of the compounded drugs
Cold temperatures slam the brakes on these molecular interactions, preserving the peptides integrity for the long haul
Once matched, pairs enter habituation cages to adapt to wild conditions